CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,895,466
- in 17 filings, $4.4M under 10b5-1 plans
Net −$4,895,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | BURKE WILLIAM W Director | Option exercise 10b5-1 | +18,000 | $4.70 | $85K | 41,022 |
| 2026-11-12 | BURKE WILLIAM W Director | Sale 10b5-1 | −16,845 | $26.58 | $448K | 24,177 |
| 2026-11-12 | BURKE WILLIAM W Director | Sale 10b5-1 | −1,155 | $27.48 | $32K | 23,022 |
| 2026-11-12 | BURKE WILLIAM W Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,000 | 7,151 | ||
| 2026-11-09 | Taylor Joseph Michael Director | Sale | −10,200 | $27.22 | $278K | 38,278 |
| 2026-11-02 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +4,864 | $3.65 | $18K | 207,982 |
| 2026-11-02 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +23 | $4.70 | $108 | 208,005 |
| 2026-11-02 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −4,887 | $26.96 | $132K | 203,118 |
| 2026-11-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,864 | 43,773 | ||
| 2026-11-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23 | 18,998 | ||
| 2026-10-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +4,864 | $3.65 | $18K | 207,982 |
| 2026-10-01 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +23 | $4.70 | $108 | 208,005 |
| 2026-10-01 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −4,887 | $24.38 | $119K | 203,118 |
| 2026-10-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,864 | 48,637 | ||
| 2026-10-01 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23 | 19,021 | ||
| 2026-09-15 | Chao Xingjuan President and CEO | Sale 10b5-1 | −20,846 | $25.03 | $522K | 746,345 |
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +846 | $9.41 | $8K | 147,446 |
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −846 | $25.00 | $21K | 146,600 |
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −846 | 51,802 | ||
| 2026-09-08 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −1,755 | $24.26 | $43K | 34,144 |
Page 1 of 17 · 334 trades